180 Life Sciences Corp.

Recent private placements and follow-on financings show that despite public company valuations being down across the board during the past two years, it still is possible to drum up investor support f

The UK Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration have both asked California-based biotech 180 Life Sciences for extra information about the use of a

Scrip regularly reviews technology transfer activity across the biopharmaceutical sector. Recent editions of Tech Transfer Roundup focused on oncology and COVID-19 deals. This reviews the rest of

With understanding of immune function advancing in leaps and bounds and a continuing proliferation of tools to manipulate it, expectations are high for advances in oncology and immunology over the com